Quality of life of patients with rheumatic diseases during the COVID-19 pandemic: The biopsychosocial path.

ABSTRACT:

Background

Previous models that assess quality-of-Life (QoL) in patients with rheumatic diseases have a strong biomedical focus. We evaluated the impact of COVID-19 related-health care interruption (HCI) on the physical, psychological, social relationships and environment QoL-dimensions, and explored factors associated with QoL when patients were reincorporated to the outpatient clinic, and after six-month follow-up.

Patients and methods

Study phase-1 consisted of a COVID-19 survey administered from June 24th-October 31st 2020, to outpatients with rheumatic diseases who had face-to-face consultation at outpatient clinic reopening. Study phase-2 consisted of 3 consecutive assessments of patient´s QoL (WHOQOL-BREF), disease activity/severity (RAPID-3), and psychological comorb

SUBMITTER: Guaracha-Basanez GA 

PROVIDER: S-EPMC8765619 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature